In a time where almost no niche area is left unexplored, life science organizations need to assess the competitive landscape for a therapeutic area and prioritize their R&D spend accordingly. Informed decision-making is pivotal to the successful development and commercialization of a new drug, and companies need to have a streamlined process for gaining strategic input from multiple functional teams along a product's development cycle to help navigate the competitive landscape.
The 4th
New Product Planning Summit serves as an educational platform for new product development, commercial planning, brand strategy, and marketing professionals to discuss how to utilize tools and resources to optimize early decision-making, collaborate with cross-functional partners to guide product development, and leverage key insights to tailor a product plan to ensure the successful launch of a new product.
Top Five Reasons to Attend:
- Learn about perspectives and best practices for new product planning from across different therapeutic areas, geographies and healthcare segments
- Examine portfolio optimization and prioritization metrics that demonstrate the value of pipeline planning and support business cases for new products
- Develop a global marketing communication and a launch strategy that is impactful and tailored to the needs of regional affiliates
- Explore the use of real-world evidence to enhance the value proposition of new products
- Examine how new product planning functions are structured, governed and operated at various companies and the key challenges they face
Who Should Attend
This conference is designed for representatives from pharmaceutical, biotechnology, and medical device companies with responsibilities in the following areas:
- New Product Planning
- Commercial Assessment/Strategy
- Competitive Intelligence
- Market Research
- Decision Support
- Health Economics and Outcomes Research
- Market Access/Pricing
- Reimbursement Strategy
- Research and Development
- Brand Commercialization
- Medical Strategy
- Clinical Research/Development
- Pharmacology/Pharmacokinetics/Pharmacodynamics
- Portfolio Management
- Regulatory Affairs/Compliance
- Medical Affairs
- Product Development
- Intellectual Property/Legal
- Scientific/Medical Communication
- Publication Planning
Speakers
- Michael P. Bentivegna, Vice President, Commercial Development and Lifecycle Innovation, ZOETIS
- Alexander Brown, Global Head, New Product Planning Oncology, SANOFI
- Erin Brubaker, Vice President of Commercial Strategy and Business Development, ZAFGEN
- Eric Gornstein, Head of New Product Planning, TALARIS THERAPEUTICS
- Paul Harney, President, North America, PRESCIENT HEALTHCARE GROUP
- Elaine Hughes, MBA, Executive Director, Commercial Development, CELGENE
- Christine Leighland, Head, New Product Planning, BIOGEN
- Nayahmka McGriff-Lee, Product and Portfolio Strategy Director, Early Pipeline and Portfolio Strategy, GSK
- Parag V. Meswani, Pharm.D., SVP, Commercial Strategy and Operations, AXOVANT SCIENCES
- Arup Pramanik, Vice President, Market Access and Strategy, INDIVIOR
- Anne Marie Robertson, Vice President, Onivyde Marketing, North American Commercial Operations, IPSEN BIOPHARMACEUTICALS
- Tony Russell, Executive Director, Product Strategy and Commercial Planning, THERAVANCE BIOPHARMA
- Reka Shinkle, Vice President, Commercial and Portfolio Planning, REGENXBIO
- Debasish Talukdar, Global Head of Advisory, PRESCIENT HEALTHCARE GROUP
- Katja Wachtendonk, Worldwide Director New Products, NOVARTIS PHARMACEUTICALS
Please fill in your name and email to receive the Summit Agenda of this event.
Venue
Revere Hotel Boston Common
200 Stuart St, 02116
Boston, MA, USA
To make reservations, please call 1-855-673-8373 and request the group rate for this December Meetings. You may also make reservations online
Click here.
The group rate is available until November 11, 2019. Please book your room early, as rooms available at this rate are limited.
